Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 72 | 72 | 72 | 71 | 0 |
| Cost of Goods | 6 | 6 | 6 | 5 | N/A |
| Gross Profit | 66 | 66 | 66 | 66 | N/A |
| Operating Expenses | 4,778 | 3,928 | 3,700 | 2,816 | 2,202 |
| Operating Income | -4,706 | -3,856 | -3,628 | -2,744 | -2,202 |
| Interest Expense | 5 | 5 | 2 | 3 | 269 |
| Other Income | 318 | 229 | -278 | 6,929 | -195 |
| Pre-tax Income | -4,393 | -3,631 | -3,907 | 4,182 | -2,666 |
| Income Tax | N/A | N/A | N/A | 25 | N/A |
| Net Income Continuous | -4,393 | -3,631 | -3,907 | 4,157 | -2,666 |
| Net Income Discontinuous | N/A | -70 | -1 | -253 | -371 |
| Net Income | $-4,393 | $-3,701 | $-3,909 | $3,904 | $-3,038 |
| EPS Basic Total Ops | -1.19 | -1.20 | -1.71 | 1.32 | -0.06 |
| EPS Basic Continuous Ops | -1.19 | -1.18 | -1.71 | 1.45 | -0.05 |
| EPS Basic Discontinuous Ops | N/A | -0.02 | 0.00 | -0.13 | -0.01 |
| EPS Diluted Total Ops | -1.19 | -1.20 | -1.71 | 1.32 | -0.06 |
| EPS Diluted Continuous Ops | -1.19 | -1.18 | -1.71 | 1.43 | -0.05 |
| EPS Diluted Discontinuous Ops | N/A | -0.02 | 0.00 | -0.13 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -1.19 | -1.18 | N/A | N/A | N/A |
| EBITDA(a) | $-4,700 | $-3,766 | $-3,628 | $-2,636 | $-1,355 |